Serial testing of CD4+ T-lymphocytes, CD8+ T-lymphocytes, and their ratio in peripheral blood T-lymphocytes and their subpopulations in patients with COVID-19 helps us to understand the state of cellular immune function in patients. The gene discussed is CD8A; the disease is COVID-19.